Delivery Order SPE2DB22D1202-SPE2DB24FVGX7

Award Date 7/15/24
Potential Completion Date 7/16/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of KENALOG-40 200 MG/5 ML VIAL 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $3,095.16 with a firm fixed price and a completion date of May 23, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,429.03 firm-fixed-price delivery order is for the supply of KENALOG-40 200 MG/5 ML VIAL 5ML, a pharmaceutical product. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,761.60 firm fixed-price delivery order is for KENALOG-40 200 MG/5 ML VIAL 5ML, a pharmaceutical product. The award is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,928.00 firm fixed price delivery order is for the supply of KENALOG-40 400 MG/10 ML VIAL 10ML, a prescription medication. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a...
The U.S. Defense Logistics Agency (DLA) awarded a $3,823.19 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of KENALOG 40MG/ML 5ML 1S pharmaceutical products. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical and medical supplies to DLA facilities supporting the Department of Defense...
This federal contract award is a delivery order with a ceiling value of $1,650.60 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the supply of KENALOG-40 400 MG/10 ML VIAL 10ML, a pharmaceutical product, with a period of performance extending through May 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,569.56 firm fixed-price delivery order is for the supply of KENALOG-40 200 MG/5 ML VIAL 5ML, a corticosteroid medication, to support federal healthcare programs. The award has an ultimate completion date of September 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of KENALOG-40 40 MG/ML VIALML. The contract has a ceiling value of $1,281.98 and a period of performance through April 12, 2024. This delivery order falls under Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,091.65 firm-fixed-price delivery order is for the supply of 200 mg/5 ml vials of the pharmaceutical product KENALOG-40. This contract is not designated as a set-aside and has an ultimate completion date of August 23, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award is for the delivery of KENALOG-40 200 MG/5 ML VIAL 5ML pharmaceutical products to the Defense Logistics Agency (DLA), a major defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, on a firm fixed-price basis. The contract has a ceiling value of $1,204.36 and an ultimate completion date of June 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVGX7
    Delivery Order

This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency, to provide a variety of pharmaceutical products and medical supplies. The $1,874.70 firm fixed price delivery order is for the supply of 4565152600 KENALOG-40 200 MG/5 ML VIAL 5ML.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical and medical products to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation.

Generated 10/14/24, 10:24 AM